{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:52:01Z","timestamp":1788911521758,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US Services Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"AstraZeneca UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019266","name":"GlaxoSmithKline Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020155","name":"Maze Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim International GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gim.2025.101521","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T19:42:40Z","timestamp":1751917360000},"page":"101521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure"],"prefix":"10.1016","volume":"27","author":[{"given":"Erja","family":"Nyn\u00e4s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sulkava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Suvanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-2976","authenticated-orcid":false,"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.gim.2025.101521_bib1","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.1407909111","article-title":"Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer","volume":"111","author":"Kiiski","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.gim.2025.101521_bib2","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1093\/hmg\/ddv251","article-title":"FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor","volume":"24","author":"Peterlongo","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-017-4388-0","article-title":"FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population","volume":"166","author":"Kiiski","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.gim.2025.101521_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","article-title":"Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer","volume":"3","author":"Neidhardt","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-019-0127-5","article-title":"The FANCM:p.Arg658\u2217 truncating variant is associated with risk of triple-negative breast cancer","volume":"5","author":"Figlioli","year":"2019","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.gim.2025.101521_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes\u2014association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"7993","key":"10.1016\/j.gim.2025.101521_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41523-021-00338-1","article-title":"Protein truncating variants in FANCM and risk for ER-negative\/triple negative breast cancer","volume":"7","author":"Peterlongo","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"9","key":"10.1016\/j.gim.2025.101521_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ng1626","article-title":"A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M","volume":"37","author":"Meetei","year":"2005","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood-2009-02-207811","article-title":"Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M","volume":"114","author":"Singh","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gim.2025.101521_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/gim.2017.124","article-title":"Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia","volume":"20","author":"Bogliolo","year":"2018","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101521_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/gim.2017.123","article-title":"Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility","volume":"20","author":"Catucci","year":"2018","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2025.101521_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.19059","article-title":"Myelodysplastic syndrome and multiple solid tumours in an individual with compound heterozygous deleterious FANCM variants: a case report and review of the literature","volume":"203","author":"Ng","year":"2023","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.gim.2025.101521_bib14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428194.2019.1711075","article-title":"Severe chemotherapy toxicity in a 10-year-old with T-acute lymphoblastic lymphoma harboring biallelic FANCM variants","volume":"61","author":"Ryland","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.gim.2025.101521_bib15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/PO.21.00110","article-title":"Ovarian failure preceding head and neck squamous cell carcinoma identifies an adult-onset cancer-prone syndrome caused by FANCM mutations","volume":"5","author":"Vellanki","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104399","article-title":"Fanconi-like anemia related to a FANCM mutation","volume":"65","author":"Encarnaci\u00f3n","year":"2022","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41436-018-0015-7","article-title":"A homozygous FANCM frameshift pathogenic variant causes male infertility","volume":"21","author":"Yin","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101521_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30490","article-title":"A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency","volume":"6","author":"Fouquet","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.gim.2025.101521_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104246","article-title":"Genetic landscape of a large cohort of Primary Ovarian Insufficiency: new genes and pathways and implications for personalized medicine","volume":"84","author":"Heddar","year":"2022","journal-title":"EBiomedicine"},{"issue":"2","key":"10.1016\/j.gim.2025.101521_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajhg.2018.07.005","article-title":"Bi-allelic recessive loss-of-function variants in FANCM cause non-obstructive azoospermia","volume":"103","author":"Kasak","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gim.2025.101521_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.799886","article-title":"Novel bi-allelic variants of FANCM cause Sertoli cell-only syndrome and non-obstructive azoospermia","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Genet"},{"issue":"7944","key":"10.1016\/j.gim.2025.101521_bib22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gim.2025.101521_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/humu.23348","article-title":"VariantValidator: accurate validation, mapping, and formatting of sequence variation descriptions","volume":"39","author":"Freeman","year":"2018","journal-title":"Hum Mutat"},{"issue":"7809","key":"10.1016\/j.gim.2025.101521_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.gim.2025.101521_bib25","doi-asserted-by":"crossref","first-page":"bax028","DOI":"10.1093\/database\/bax028","article-title":"GeneHancer: genome-wide integration of enhancers and target genes in GeneCards","volume":"2017","author":"Fishilevich","year":"2017","journal-title":"Database (Oxford)"},{"issue":"6235","key":"10.1016\/j.gim.2025.101521_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"Ardlie","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.gim.2025.101521_bib27","author":"Alboukadel Kassambara"},{"key":"10.1016\/j.gim.2025.101521_bib28","series-title":"GeneReviews\u00ae","article-title":"Fanconi Anemia","author":"Mehta","year":"2002"},{"issue":"5","key":"10.1016\/j.gim.2025.101521_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.gim.2025.101521_bib30","doi-asserted-by":"crossref","first-page":"50930","DOI":"10.18632\/oncotarget.15871","article-title":"Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene","volume":"8","author":"Dicks","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.gim.2025.101521_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1532","article-title":"FANCM c5791C>T stopgain mutation (rs144567652) is a familial colorectal cancer risk factor","volume":"8","author":"Cannon-Albright","year":"2020","journal-title":"Molec Gen & Gen Med"},{"issue":"2","key":"10.1016\/j.gim.2025.101521_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cncr.11046","article-title":"Cancer in Fanconi anemia, 1927-2001","volume":"97","author":"Alter","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gim.2025.101521_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/bjc.2011.250","article-title":"What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries","volume":"105","author":"Sasieni","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gim.2025.101521_bib34","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/lary.25726","article-title":"Natural history and management of Fanconi anemia patients with head and neck cancer: a 10-year follow-up","volume":"126","author":"Kutler","year":"2016","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.gim.2025.101521_bib35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00439-022-02462-9","article-title":"Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair","volume":"141","author":"Peake","year":"2022","journal-title":"Hum Genet"},{"issue":"18","key":"10.1016\/j.gim.2025.101521_bib36","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1093\/hmg\/ddp297","article-title":"Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M","volume":"18","author":"Bakker","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101521_bib37","first-page":"4","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat Res Fundam Mol Mech Mutagen"},{"issue":"2","key":"10.1016\/j.gim.2025.101521_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beem.2010.08.006","article-title":"Male infertility: pathogenesis and clinical diagnosis","volume":"25","author":"Krausz","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.gim.2025.101521_bib41","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/ijc.30394","article-title":"FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome","volume":"139","author":"Kiiski","year":"2016","journal-title":"Int J Cancer"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:13:40Z","timestamp":1786691620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1098360025001686"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101521","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101521"}}